Hony Capitalis is an investment management firm.
Business Model: B2B
Revenue: $34.7M
Employees: 51-200
Address: 6th floor, South Tower C, Raycom InfoTech Park, No. 2,
City: Beijing
State: beijing municipality
Zip: 100190
Country: CN
Founded in 2003, Hony Capital is a pioneer in China’s home grown private equity industry. Sponsored by Legend Holdings, a leading Chinese conglomerate, Hony has blazed the trail in formulating private equity investment strategies suitable for Chinese conditions by combining a deep understanding of local environment and people with global resources and international best practices. Today, with over USD 6.8 billion in assets under management across 7 funds and investments in over 60 companies, Hony is a leading China-focused private equity firm. Adhering to the “value creation” investment philosophy, Hony partners with managers and entrepreneurs to build their businesses into sustainable leaders in respective industries. Hony focuses on sectors where it has developed expertise: pharmaceuticals and healthcare, consumer &a; retail, media &a; entertainment, financial services, construction materials, machinery, and alternative energy &a; resources
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2017 | Zihuangbao | Series A | 3M |
7/2021 | Shenzhen Jijia | Series A | 0 |
10/2017 | Mr&a;Mrs Italy | Funding Round | - |
12/2016 | Xishaoye Roujiamo | Venture Round | 11.5M |
7/2018 | WeWork China | Series B | 500M |
7/2017 | WeWork China | Series A | 0 |
3/2019 | STX Entertainment | Private Equity Round | 700M |
3/2021 | EpimAb Biotherapeutics | Series C | 0 |
5/2015 | Tuniu | Post-IPO Equity | 500M |
8/2017 | WeWork | Series G | 0 |
8/2021 | Seesaw Coffee | Series A | 0 |
12/2014 | Neusoft Medical Systems | Secondary Market | 180M |
12/2014 | Neusoft Medical Systems | Venture Round | 260M |
12/2021 | Fuji Inc | Seed Round | - |
7/2021 | G+ ERP | Series A | 0 |
7/2018 | Qianqiu old culture | Series B | - |
4/2016 | Zispace | Angel Round | 461.8k |
3/2014 | STX Entertainment | Venture Round | - |
5/2021 | Chongxing Chongwu | Series B | 0 |
9/2021 | RootPath Genomics | Series B | 50M |
12/2014 | Tuniu | Post-IPO Equity | 148M |
12/2010 | Uyoung | Angel Round | 454.5k |
6/2017 | Seesaw Coffee | Series A | 6.6M |
7/2011 | Sundan | Angel Round | 463.9k |
4/2016 | Deem | Venture Round | 0 |
7/2014 | Deem | Private Equity Round | 50M |
2/2021 | Fenbi | Series A | 390M |
12/2020 | Chongxing Chongwu | Series B | 30.6M |
4/2021 | Dingdong Maicai | Series D | 0 |
12/2014 | XIKANG | Series A | 170M |
6/2018 | I-Mab Biopharma | Series C | 0 |
12/2020 | Nourse | Series B | 30.6M |
7/2017 | ofo | Series E | 700M |
11/2016 | WeWork | Series F | 0 |
6/2021 | StarPony | Seed Round | - |
5/2022 | Starna Therapeutics | Series A | 0 |
3/2021 | Xiaomian | Series B | 2M |
8/2017 | Vuclip | Venture Round | 110M |
10/2022 | Veminsyn | Series A | 13.8M |
11/2017 | Xinyisoft | Corporate Round | - |
3/2021 | Houmo.AI | Seed Round | - |
4/2010 | Happigo | Series A | 43.9M |
3/2016 | Ningmeng Pictures | Series B | 0 |
7/2021 | Seesaw Coffee | Series A | 0 |
3/2016 | Linmon Pictures | Series B | 0 |
12/2017 | Amber Aviation | Series A | - |
3/2017 | SexySalad | Series B | 7.2M |
5/2017 | Qianqiu old culture | Series A | - |
6/2019 | Meishubao | Series C | 40M |
3/2018 | Linmon Pictures | Series C | - |
9/2019 | Xinhua Xuanmen | Private Equity Round | 42.2M |
10/2017 | Yatsen Holding | Series B | 3.8M |
4/2020 | Eros STX Global | Post-IPO Equity | 125M |
10/2013 | PPTV | Private Equity Round | 420M |
5/2022 | Starna Therapeutics | Series A | 0 |
12/2021 | Fuji Inc | Seed Round | - |
9/2021 | RootPath Genomics | Series B | 0 |
8/2021 | Seesaw Coffee | Series A | 0 |
7/2021 | Seesaw Coffee | Series A | 0 |
7/2021 | Shenzhen Jijia | Series A | 0 |
7/2021 | G+ ERP | Series A | 0 |
6/2021 | StarPony | Seed Round | - |
5/2021 | Chongxing Chongwu | Series B | 0 |
4/2021 | Dingdong Maicai | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|